Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| SK-BR-3 | Erlotinib | 0.031623 | uM | 9 | 2500.00 | 1861.36 | 4145.00 | 3777.75 | 1.0972 | 1.1902 |
| SK-BR-3 | Erlotinib | 1 | uM | 9 | 2500.00 | 1861.36 | 3955.00 | 3777.75 | 1.0469 | 1.0918 |
| SK-BR-3 | 17-AAG | 0.000302 | uM | 9 | 2500.00 | 1861.36 | 4118.00 | 3777.75 | 1.0901 | 1.1762 |
| SK-BR-3 | Lapatinib | 3.1623 | uM | 9 | 2500.00 | 1861.36 | 1582.00 | 3777.75 | 0.4188 | -0.1472 |
| SK-BR-3 | 17-AAG | 0.31623 | uM | 9 | 2500.00 | 1861.36 | 1361.00 | 3777.75 | 0.3603 | -0.2641 |
| SK-BR-3 | 0 | uM | 9 | 2500.00 | 1861.36 | 3643.00 | 3777.75 | 0.9643 | 0.9301 | |
| SK-BR-3 | 0 | uM | 9 | 2500.00 | 1861.36 | 3678.00 | 3777.75 | 0.9736 | 0.9483 | |
| SK-BR-3 | Linsitinib | 1 | uM | 9 | 2500.00 | 1861.36 | 3511.00 | 3777.75 | 0.9294 | 0.8616 |
| SK-BR-3 | Erlotinib | 0.31623 | uM | 9 | 2500.00 | 1861.36 | 3816.00 | 3777.75 | 1.0101 | 1.0198 |
| SK-BR-3 | 0 | uM | 9 | 2500.00 | 1861.36 | 3992.00 | 3777.75 | 1.0567 | 1.1110 | |
| SK-BR-3 | Linsitinib | 19.9526 | uM | 9 | 2500.00 | 1861.36 | 2406.00 | 3777.75 | 0.6369 | 0.2857 |
| SK-BR-3 | Linsitinib | 0.0033113 | uM | 9 | 2500.00 | 1861.36 | 4200.00 | 3777.75 | 1.1118 | 1.2187 |
| SK-BR-3 | Erlotinib | 10 | uM | 9 | 2500.00 | 1861.36 | 1752.00 | 3777.75 | 0.4638 | -0.0576 |
| SK-BR-3 | Erlotinib | 3.1623 | uM | 9 | 2500.00 | 1861.36 | 3414.00 | 3777.75 | 0.9037 | 0.8112 |
| SK-BR-3 | 17-AAG | 0.0031623 | uM | 9 | 2500.00 | 1861.36 | 3869.00 | 3777.75 | 1.0242 | 1.0473 |
| SK-BR-3 | Erlotinib | 0.01 | uM | 9 | 2500.00 | 1861.36 | 4372.00 | 3777.75 | 1.1573 | 1.3076 |
| SK-BR-3 | Linsitinib | 0.01 | uM | 9 | 2500.00 | 1861.36 | 4364.00 | 3777.75 | 1.1552 | 1.3035 |
| SK-BR-3 | 17-AAG | 0.0001 | uM | 9 | 2500.00 | 1861.36 | 4315.00 | 3777.75 | 1.1422 | 1.2781 |
| SK-BR-3 | 17-AAG | 0.01 | uM | 9 | 2500.00 | 1861.36 | 2305.00 | 3777.75 | 0.6102 | 0.2329 |
| SK-BR-3 | Linsitinib | 10 | uM | 9 | 2500.00 | 1861.36 | 3049.00 | 3777.75 | 0.8071 | 0.6214 |
| SK-BR-3 | 0 | uM | 9 | 2500.00 | 1861.36 | 4007.00 | 3777.75 | 1.0607 | 1.1188 | |
| SK-BR-3 | Lapatinib | 1 | uM | 9 | 2500.00 | 1861.36 | 1352.00 | 3777.75 | 0.3579 | -0.2688 |
| SK-BR-3 | Lapatinib | 10 | uM | 9 | 2500.00 | 1861.36 | 1407.00 | 3777.75 | 0.3724 | -0.2397 |
| SK-BR-3 | Lapatinib | 0.0033113 | uM | 9 | 2500.00 | 1861.36 | 3753.00 | 3777.75 | 0.9935 | 0.9872 |
| SK-BR-3 | Linsitinib | 0.1 | uM | 9 | 2500.00 | 1861.36 | 3908.00 | 3777.75 | 1.0345 | 1.0675 |